Gottschalk A, Smith D S, Jobes D R, Kennedy S K, Lally S E, Noble V E, Grugan K F, Seifert H A, Cheung A, Malkowicz S B, Gutsche B B, Wein A J
Department of Anesthesia, School of Medicine, University of Pennsylvania, Philadelphia 19104, USA.
JAMA. 1998 Apr 8;279(14):1076-82. doi: 10.1001/jama.279.14.1076.
Preemptive analgesia can decrease the sensitization of the central nervous system that would ordinarily amplify subsequent nociceptive input, but a clear demonstration of its clinical efficacy is necessary for it to become a routine component of acute pain therapy.
To determine the impact of preemptive epidural analgesia on postoperative pain and other clinically important outcome variables after radical retropubic prostatectomy.
A block randomized double-blind clinical trial lasting 20 months at a single academic medical center.
A total of 100 generally healthy and neurologically intact patients scheduled for radical retropubic prostatectomy for the treatment of prostate cancer in whom an epidural catheter for treating postoperative pain was to be placed prior to the induction of general anesthesia.
Epidural bupivacaine, epidural fentanyl, or no epidural drug was administered prior to induction of anesthesia and throughout the entire operation, followed by aggressive postoperative epidural analgesia for all patients.
Daily pain scores during hospitalization and pain scores obtained 3.5, 5.5, and 9.5 weeks after hospital discharge.
The patients who received epidural fentanyl or bupivacaine prior to surgical incision (preemptive analgesia) experienced 33% less pain while hospitalized (P=.007). Pain scores in those receiving preemptive analgesia were significantly lower at 9.5 weeks (P=.02), but were not significantly different at 3.5 or 5.5 weeks. At 9.5 weeks, 32 (86%) of 37 patients receiving preemptive analgesia were pain-free compared with 9 (47%) of 19 control patients (P=.004). Patients receiving preemptive analgesia were more active 3.5 weeks after surgery (P=.01), but not at 5.5 or 9.5 weeks.
Even in the presence of aggressive postoperative pain management, preemptive epidural analgesia significantly decreases postoperative pain during hospitalization and long after discharge, and is associated with increased activity levels after discharge.
超前镇痛可降低中枢神经系统的敏化,否则该系统会增强随后的伤害性刺激输入,但要使其成为急性疼痛治疗的常规组成部分,还需要明确证明其临床疗效。
确定超前硬膜外镇痛对耻骨后根治性前列腺切除术后疼痛及其他重要临床结局变量的影响。
在一家学术医疗中心进行的一项为期20个月的整群随机双盲临床试验。
总共100例一般健康且神经功能完好、计划行耻骨后根治性前列腺切除术治疗前列腺癌的患者,在全身麻醉诱导前需放置硬膜外导管用于术后镇痛。
麻醉诱导前及整个手术过程中,给予硬膜外布比卡因、硬膜外芬太尼或不给予硬膜外药物,所有患者术后均进行积极的硬膜外镇痛。
住院期间的每日疼痛评分以及出院后3.5、5.5和9.5周时的疼痛评分。
手术切口前接受硬膜外芬太尼或布比卡因(超前镇痛)的患者住院期间疼痛减轻33%(P = 0.007)。接受超前镇痛的患者在9.5周时疼痛评分显著更低(P = 0.02),但在3.5或5.5周时无显著差异。在9.5周时,37例接受超前镇痛的患者中有32例(86%)无疼痛,而19例对照患者中有9例(47%)无疼痛(P = 0.004)。接受超前镇痛的患者术后3.5周时活动更积极(P = 0.01),但在5.5或9.5周时并非如此。
即使在积极进行术后疼痛管理的情况下,超前硬膜外镇痛仍可显著降低住院期间及出院后很长时间的术后疼痛,并与出院后活动水平增加相关。